Azathioprine is an immunosuppressant used widely in the treatment of various autoimmune diseases. He was extracted from the analysis of the results of randomized trials 7 (five and two double-blind, single blind) with patients who suffer from MS 793 by oral azathioprine (1-3 mg/kg/m2) reduces the frequency of relapses and little impact very EDSS. These results have been criticized on the grounds that used a sufficient dose of azathioprine in some studies. Side effects of azathioprine toxicity, gastrointestinal tract, and blood and liver. Another risk potential long-term cancer, but in the controlled trial, case-control, short-term (less than 5 years) are not associated with significantly increased risk. Treatment requires close monitoring and ongoing patient, including blood counts and liver function tests.
